LipiFlow for the treatment of dry eye disease-Reference-Cited by-同舟云学术

LipiFlow for the treatment of dry eye disease

Published:2024-02-05 Issue:2 Volume:2024 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Pucker Andrew D¹,Yim Tsz Wing²,Rueff Erin³,Ngo William⁴,Tichenor Anna A⁵,Conto John E⁶

Affiliation:

1. Clinical and Medical Science; Lexitas Pharma Services; Durham North Carolina USA

2. Department of Ophthalmology; University of Colorado Anschutz Medical Campus; Aurora Colorado USA

3. The Southern California College of Optometry; Marshall B. Ketchum University; Fullerton California USA

4. School of Optometry & Vision Science; University of Waterloo; Waterloo Canada

5. Indiana University School of Optometry; Bloomington Indiana USA

6. Ophthalmology and Visual Science; Medical College of Wisconsin; Milwaukee Wisconsin USA

Publisher

Wiley

Subject

Pharmacology (medical)

Reference93 articles.

1. Meibomian gland dysfunction: a comparative study of modern treatments;Baumann;Journal Français d'Ophtalmologie,2014

2. Comparison of an automated thermodynamic treatment system (LipiFlow) and warm compresses for the treatment of moderate severity of meibomian gland dysfunction;Booranapong;Siriraj Medical Journal,2019

3. Comparison of an automated thermodynamic treatment system (LipiFlow®) and eyelid warm compress for the treatment of meibomian gland dysfunction trialsearch.who.int/Trial2.aspx?TrialID=TCTR20170905001

4. TearCare for the treatment of meibomian gland dysfunction in adult patients with dry eye disease: a masked randomized controlled trial;Gupta;Cornea,2022

5. Comparison of a single-dose vectored thermal pulsation procedure with a 3-month course of daily oral doxycycline for moderate-to-severe meibomian gland dysfunction;Hagen;Clinical Ophthalmology (Auckland, NZ),2018